These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The prevalence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Bacteroides forsythus in humans 1 year after 4 randomized treatment modalities. Shiloah J; Patters MR; Dean JW; Bland P; Toledo G J Periodontol; 1998 Dec; 69(12):1364-72. PubMed ID: 9926766 [TBL] [Abstract][Full Text] [Related]
9. Risk assessment for severe clinical attachment loss in an adult population. Bouchard P; Boutouyrie P; Mattout C; Bourgeois D J Periodontol; 2006 Mar; 77(3):479-89. PubMed ID: 16512763 [TBL] [Abstract][Full Text] [Related]
10. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study. Mengel R; Schreiber D; Flores-de-Jacoby L J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123 [TBL] [Abstract][Full Text] [Related]
11. The association between gingival crevicular fluid TGF-beta1 levels and periodontal status in HIV-1(+) patients. Alpagot T; Konopka K; Bhattacharyya M; Gebremedhin S; Düzgüneş N J Periodontol; 2008 Jan; 79(1):123-30. PubMed ID: 18166101 [TBL] [Abstract][Full Text] [Related]
13. Smoking affects the subgingival microflora in periodontitis. van Winkelhoff AJ; Bosch-Tijhof CJ; Winkel EG; van der Reijden WA J Periodontol; 2001 May; 72(5):666-71. PubMed ID: 11394403 [TBL] [Abstract][Full Text] [Related]
14. Depressive symptoms in relation to periodontal health in a Jordanian sample. Ababneh KT; Al Shaar MB; Taani DQ Int J Dent Hyg; 2010 Feb; 8(1):16-21. PubMed ID: 20096077 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 gene polymorphisms and long-term stability following guided tissue regeneration therapy. De Sanctis M; Zucchelli G J Periodontol; 2000 Apr; 71(4):606-13. PubMed ID: 10807125 [TBL] [Abstract][Full Text] [Related]
16. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study. Mengel R; Soffner M; Flores-de-Jacoby L J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of four modalities of periodontal therapy. Mean probing depth, probing attachment level and recession changes. Kaldahl WB; Kalkwarf KL; Patil KD; Dyer JK; Bates RE J Periodontol; 1988 Dec; 59(12):783-93. PubMed ID: 3066888 [TBL] [Abstract][Full Text] [Related]
19. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis. Erdemir EO; Duran I; Haliloglu S J Clin Periodontol; 2004 Feb; 31(2):99-104. PubMed ID: 15016034 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis. Tüter G; Kurtiş B; Serdar M J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]